Two years later, the same group demonstrated that H19 regulated E2F1 expression by sponging miR-675, which served as an underlying biomarker for diagnosing pancreatic cancer (Fig. 1Y1) 78. The gene discussed is E2F1; the disease is familial pancreatic carcinoma.